Amid mounting calls across the world to ban the controversial use of transvaginal mesh to treat pelvic organ prolapse (POP), Israeli company POP Medical Solutions is introducing NeuGuide, an FDA-cleared minimally invasive repair system uniquely requiring neither dissection nor mesh.
POP is a common but painful and debilitating condition in which pelvic organs (uterus, vagina, bladder or rectum) sag or drop. Up to half of all women experience POP in their lifetime – especially as they age – making this a $1 billion market. The incidence of POP is expected to rise with increasing life expectancy and obesity.